Antimutagenic Agents

DBCAT001505Pharmacologic class

Agents that reduce the frequency or rate of spontaneous or induced mutations independently of the mechanism involved. A DrugBank category of 4 drugs. 2 of them are approved.

Also known as: Agents, Anti-Mutagenic · Agents, Antimutagenic · Anti Mutagenic Agents · Anti Mutagenic Effect · Anti Mutagenic Effects
Drugs: Cinnamaldehyde
Cobalt chloride
Epigallocatechin gallate
Sodium copper chlorophyllin

What you can answer from here — as of August 24, 2016

4DrugsEach linked to its full drug card

Listed above

17Drug targetsEvery drug–target pair in the class, with bond type

6Marketed productsAcross the regions we cover, with dosage forms and routes

4Routes of administrationHow the drugs in this class are given

Which targets do Antimutagenic Agents share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account